Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 5Cholangiocarcinoma 4Neoplasm Metastasis 2Jaundice 2Gallbladder Neoplasms 2Colonic Neoplasms 2Bites and Stings 2Bile Duct Neoplasms 2Urologic Diseases 1Urolithiasis 1Urinary Calculi 1Ureterolithiasis 1Ureteral Obstruction 1Renal Insufficiency 1Rectal Neoplasms 1Pyonephrosis 1Pyelonephritis 1Nephrolithiasis 1Klatskin Tumor 1Kidney Diseases 1Kidney Calculi 1Infections 1Hydronephrosis 1Head and Neck Neoplasms 1Fistula 1Duodenal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Hepatocellular 1Calculi 1Acute Kidney Injury 1

Interventions

Gemcitabine 6Cisplatin 6Capecitabine 6Liver Transplantation 4Fluorouracil 4Specimen Handling 3Radiosurgery 3Oxaliplatin 3Magnetic Resonance Spectroscopy 3toripalimab 2dehydroftorafur 2Self Expandable Metallic Stents 2Platinum 2Leucovorin 2Biopsy 21,2-diaminocyclohexaneplatinum II citrate 2trisacryl gelatin microspheres 1tremelimumab 1trametinib 1tislelizumab 1temoporfin 1sacituzumab govitecan 1ricolinostat 1pembrolizumab 1lenvatinib 1gemcitabine-oxaliplatin regimen 1fludarabine 1durvalumab 1binimetinib 1Tegafur 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Klatskin Tumor × Stents × Clear all
NCT02955771 2019-07-17

Efficacy and Safety Study of PDT Using Deuteporfin for Unresectable Advanced Perihilar Cholangiocarcinoma

Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.

Phase 2 Terminated
7 enrolled
Gastrointestinal

Klatskin Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡